ArticleBMC infectious diseases2026
Preterm birth and the risk of respiratory syncytial virus hospitalisation in Australia's Northern Territory: a population-based cohort study.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe Northern Territory (NT) of Australia has high reported rates of both preterm birth and childhood respiratory syncytial virus (RSV) infections. The aim of this study was to investigate the association between preterm birth and risk of RSV-associated acute lower respiratory infection (RSV-ALRI) hospital admission among NT infants during their first year of life.
methodsA retrospective, population-based cohort study of NT mother-infant pairs from 2008 to 2017. Preterm birth was defined as gestation < 37 weeks. RSV-ALRI hospitalisations were identified using ICD-10-AM codes (J12.1, J20.5, J21.0, or J09-J22 plus B97.4). Risk of RSV-ALRI in preterm infants was assessed using generalised linear regression to calculate risk ratios (RR). A multivariable risk model adjusted for all available maternal, perinatal, and infant characteristics. Temporal trends in hospitalisation incidence were assessed using negative binomial regression.
resultsOverall, 10% (3839/39148) of infants were born preterm, and 2% (846/39148) were hospitalised with RSV-ALRI. Preterm infants (4%) had twice the risk of RSV-ALRI compared to term infants (2%) (risk ratio [RR] 2.26, 95% CI 1.90-2.69; adjusted RR 1.72, 95% CI 1.43-2.08), with the highest risk among those born < 32 weeks' gestation (7%). Elevated risks were also observed in First Nations infants (4.5%), infants of young mothers aged < 19 years (4.9%), those living in very remote Central desert regions (7.1%), and infants of mothers who had a urinary tract infection during pregnancy (5.1%). The episode-based RSV-ALRI hospitalisation rate was 2.3 per 100 child-years, declining steadily across the decade of observation (incidence rate ratio [IRR] 0.90 per year, 95% CI 0.86-0.94).
conclusionPreterm birth is an independent and significant risk factor for infant RSV hospitalisation in Australia's NT. Other important risk factors include younger maternal age, residence in remote or Central desert regions, maternal urinary tract infection (UTI) during pregnancy, and male sex. RSV immunisation strategies will be crucial in protecting high-risk infants in the NT and elsewhere.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.